Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Janone Inc JAN

Industrials
JanOne Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, acquiring, licensing, developing, partnering, and commercializing novel, no-opioid, and non-addictive therapies to address the large, unmet medical need for the treatment of pain and addiction. Its drug candidate, JAN101, is a patented oral, sustained-release pharmaceutical composition of sodium... see more

Recent & Breaking News (NDAQ:JAN)

One of the nation's most renowned pain experts, Dr. Edgar Ross, joins JanOne's Scientific Advisory Board

PR Newswire June 30, 2020

JanOne taps distinguished chemist Dr. Doug Flanagan as chief formulation advisor

PR Newswire June 25, 2020

JanOne Launches Strategic Alternatives Process for Legacy Businesses

PR Newswire June 18, 2020

JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development

PR Newswire February 6, 2020

Amol Soin, MD, One Of The Nation's Leading Pain Experts, Named As JanOne's Chief Medical Officer

PR Newswire January 28, 2020

JanOne Scientific Advisory Board Chair and Leading Pain Expert Featured on ABC-7 WJLA America This Week

PR Newswire January 23, 2020

Leading Cardiovascular Researcher And PAD Treatment Pioneer, Dr. Christopher Kevil, To Chair JanOne Scientific Advisory Board

PR Newswire January 16, 2020

JanOne Names Tony Giordano, Ph.D., as Chief Scientific Officer

PR Newswire December 3, 2019

JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD)

PR Newswire November 25, 2019

JanOne Names America This Week Host And Financial Commentator Eric Bolling As President And Chairman

PR Newswire September 12, 2019

Appliance Recycling Centers of America Inc. Announces Major Strategic Shift, Repositioning and Name Change

PR Newswire September 5, 2019

ARCA Announces Significant Increase in Orders in its Recycling Division

PR Newswire August 29, 2019

GeoTraq Named "Top 10 Remote Monitoring Solution Providers - 2019"

PR Newswire August 27, 2019

ARCA Recycling Opens New Syracuse, NY Recycling Center

PR Newswire August 26, 2019

CIO Bulletin Announces GeoTraq As One of the 30 Most Innovative Companies 2019

PR Newswire July 25, 2019

GeoTraq Raises the Standard for Mobile IoT by Joining GSMA

PR Newswire June 25, 2019

Polte and GeoTraq Team Up to Deliver Revolutionary Mobile IoT Asset Trackers

PR Newswire May 7, 2019

GeoTraq Announces New Class of Mobile IoT Modules

PR Newswire April 25, 2019

Appliance Recycling Centers of America Announces Reverse Stock Split of Common Stock

PR Newswire April 18, 2019

GeoTraq Announces Issuance of Patent by USPTO for Use in Company's Cellular IoT Modules

PR Newswire January 16, 2019